AHT 1170 FinalWITH COMPLETE
SOLUTION
Vaccine factors - ANS>>Age aa aa aa
Species
Travel habits aa
Previous vaccine history aa aa aa
Geographical location aa
Housing situation aa aa
Type of vaccine aa aa
Health status aa
Core vaccine - ANS>>Recommended for all animals of a certain species
aa aa aa aa aa aa aa aa aa aa
Non core vaccines - ANS>>Optional vaccines that are recommended based on need
aa aa aa aa aa aa aa aa aa aa aa
and risk
aa aa
Not recommended vaccines - ANS>>Not shown to be efficacious
aa aa aa aa aa aa aa aa
Canine core vaccines - ANS>>Canine distemper virus
aa aa aa aa aa aa
Canine parvovirus aa aa
Canine adenovirus aa aa
Rabies
Feline core vaccines - ANS>>Feline parvovirus
aa aa aa aa aa aa
Feline calcivirus aa
Feline herpesvirus aa aa
Rabies
Canine non core vaccines - ANS>>Bordetella, influenza
aa aa aa aa aa aa
Feline non core vaccines - ANS>>Feline leukaemia
aa aa aa aa aa aa aa
FIV
Pharmacology - ANS>>Study of the effect of drugs on the structure and metabolism
aa aa aa aa aa aa aa aa aa aa aa aa
of tissue
aa aa
Pharmokinetics - ANS>>The action of drugs in the body, including absorption,
aa aa aa aa aa aa aa aa aa aa
distribution, metabolism and excretion
aa aa aa aa
, Patent - ANS>>The legal right given by the government to a company that originated
aa aa aa aa aa aa aa aa aa aa aa aa aa
a new drug, exclusive rights to manufacturers for that product for a certain amount of
aa aa aa aa aa aa aa aa aa aa aa aa aa aa aa
time
aa
Toxicology - ANS>>The study of the adverse effects of chemicals on tissues or
aa aa aa aa aa aa aa aa aa aa aa aa
bodies
aa
Withdrawal period - ANS>>The amount of time that it takes for a drug to be safely
aa aa aa aa aa aa aa aa aa aa aa aa aa aa aa
eliminated from meat or milk after the use of that drug has been stopped
aa aa aa aa aa aa aa aa aa aa aa aa aa aa
Chemical name - ANS>>Describes its molecular structure
aa aa aa aa aa aa
Drug - ANS>>A substance used to diagnose, treat and prevent disease
aa aa aa aa aa aa aa aa aa aa
Generic name - ANS>>When a general drug is approved a federal agency is
aa aa aa aa aa aa aa aa aa aa aa aa
responsible for naming the drug, gives it a generic official name
aa aa aa aa aa aa aa aa aa aa aa
Trade name or brand name - ANS>>Unique exclusive name that a pharmaceutical
aa aa aa aa aa aa aa aa aa aa aa
company chooses to give to the drug that they are marketing
aa aa aa aa aa aa aa aa aa aa aa
Unapproved drug - ANS>>Does not have a DIN, never been approved by a Canadian
aa aa aa aa aa aa aa aa aa aa aa aa aa
regulatory authority
aa aa
Banned drug - ANS>>Drugs banned by health Canada from use in animals intended
aa aa aa aa aa aa aa aa aa aa aa aa
for use in human food
aa aa aa aa aa
Compound - ANS>>Mixing two or more ingredients together, at least one must be a
aa aa aa aa aa aa aa aa aa aa aa aa aa
drug
aa
Nutraceutical - ANS>>Nutrition and pharmaceutical, claims to provide a physiological
aa aa aa aa aa aa aa aa aa
benefit or protection against chronic disease, does not have DIN, and doesn't have
aa aa aa aa aa aa aa aa aa aa aa aa aa
rigorous scientific evidence of research and trial
aa aa aa aa aa aa aa
Absorption - ANS>>Process by which a drug crosses various barriers to reach the
aa aa aa aa aa aa aa aa aa aa aa aa
bloodstream
aa
Half life - ANS>>The time required for the amount of drug in the blood to be reduced
aa aa aa aa aa aa aa aa aa aa aa aa aa aa aa aa
by one half
aa aa aa
Summation (additive) - ANS>>Smaller amounts of each drug can be used, final
aa aa aa aa aa aa aa aa aa aa aa
response is equal to the sum of the individual responses to the drugs
aa aa aa aa aa aa aa aa aa aa aa aa aa
Synergism - ANS>>Final response to using two or more drugs together is greater
aa aa aa aa aa aa aa aa aa aa aa aa
than the sum of the individual responses to the drugs
aa aa aa aa aa aa aa aa aa aa
Antagonism - ANS>>Block another drug from combining with receptors
aa aa aa aa aa aa aa aa
SOLUTION
Vaccine factors - ANS>>Age aa aa aa
Species
Travel habits aa
Previous vaccine history aa aa aa
Geographical location aa
Housing situation aa aa
Type of vaccine aa aa
Health status aa
Core vaccine - ANS>>Recommended for all animals of a certain species
aa aa aa aa aa aa aa aa aa aa
Non core vaccines - ANS>>Optional vaccines that are recommended based on need
aa aa aa aa aa aa aa aa aa aa aa
and risk
aa aa
Not recommended vaccines - ANS>>Not shown to be efficacious
aa aa aa aa aa aa aa aa
Canine core vaccines - ANS>>Canine distemper virus
aa aa aa aa aa aa
Canine parvovirus aa aa
Canine adenovirus aa aa
Rabies
Feline core vaccines - ANS>>Feline parvovirus
aa aa aa aa aa aa
Feline calcivirus aa
Feline herpesvirus aa aa
Rabies
Canine non core vaccines - ANS>>Bordetella, influenza
aa aa aa aa aa aa
Feline non core vaccines - ANS>>Feline leukaemia
aa aa aa aa aa aa aa
FIV
Pharmacology - ANS>>Study of the effect of drugs on the structure and metabolism
aa aa aa aa aa aa aa aa aa aa aa aa
of tissue
aa aa
Pharmokinetics - ANS>>The action of drugs in the body, including absorption,
aa aa aa aa aa aa aa aa aa aa
distribution, metabolism and excretion
aa aa aa aa
, Patent - ANS>>The legal right given by the government to a company that originated
aa aa aa aa aa aa aa aa aa aa aa aa aa
a new drug, exclusive rights to manufacturers for that product for a certain amount of
aa aa aa aa aa aa aa aa aa aa aa aa aa aa aa
time
aa
Toxicology - ANS>>The study of the adverse effects of chemicals on tissues or
aa aa aa aa aa aa aa aa aa aa aa aa
bodies
aa
Withdrawal period - ANS>>The amount of time that it takes for a drug to be safely
aa aa aa aa aa aa aa aa aa aa aa aa aa aa aa
eliminated from meat or milk after the use of that drug has been stopped
aa aa aa aa aa aa aa aa aa aa aa aa aa aa
Chemical name - ANS>>Describes its molecular structure
aa aa aa aa aa aa
Drug - ANS>>A substance used to diagnose, treat and prevent disease
aa aa aa aa aa aa aa aa aa aa
Generic name - ANS>>When a general drug is approved a federal agency is
aa aa aa aa aa aa aa aa aa aa aa aa
responsible for naming the drug, gives it a generic official name
aa aa aa aa aa aa aa aa aa aa aa
Trade name or brand name - ANS>>Unique exclusive name that a pharmaceutical
aa aa aa aa aa aa aa aa aa aa aa
company chooses to give to the drug that they are marketing
aa aa aa aa aa aa aa aa aa aa aa
Unapproved drug - ANS>>Does not have a DIN, never been approved by a Canadian
aa aa aa aa aa aa aa aa aa aa aa aa aa
regulatory authority
aa aa
Banned drug - ANS>>Drugs banned by health Canada from use in animals intended
aa aa aa aa aa aa aa aa aa aa aa aa
for use in human food
aa aa aa aa aa
Compound - ANS>>Mixing two or more ingredients together, at least one must be a
aa aa aa aa aa aa aa aa aa aa aa aa aa
drug
aa
Nutraceutical - ANS>>Nutrition and pharmaceutical, claims to provide a physiological
aa aa aa aa aa aa aa aa aa
benefit or protection against chronic disease, does not have DIN, and doesn't have
aa aa aa aa aa aa aa aa aa aa aa aa aa
rigorous scientific evidence of research and trial
aa aa aa aa aa aa aa
Absorption - ANS>>Process by which a drug crosses various barriers to reach the
aa aa aa aa aa aa aa aa aa aa aa aa
bloodstream
aa
Half life - ANS>>The time required for the amount of drug in the blood to be reduced
aa aa aa aa aa aa aa aa aa aa aa aa aa aa aa aa
by one half
aa aa aa
Summation (additive) - ANS>>Smaller amounts of each drug can be used, final
aa aa aa aa aa aa aa aa aa aa aa
response is equal to the sum of the individual responses to the drugs
aa aa aa aa aa aa aa aa aa aa aa aa aa
Synergism - ANS>>Final response to using two or more drugs together is greater
aa aa aa aa aa aa aa aa aa aa aa aa
than the sum of the individual responses to the drugs
aa aa aa aa aa aa aa aa aa aa
Antagonism - ANS>>Block another drug from combining with receptors
aa aa aa aa aa aa aa aa
